The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Energetic Characterization of the Basic Fibroblast Growth Factor-Heparin Interaction: Identification of the Heparin Binding Domain
Abstract
Fibroblast growth factors (FGF's) interact on cell surfaces with "low-affinity" heparan sulfate proteoglycans (HSPG) and "high-affinity" FGF receptors (FGFR) to initiate cell proliferation. Previous reports have implicated the binding of heparin, or heparan sulfate, to FGF as essential for FGF-mediated signal transduction and mitogenicity. However, the molecular recognition events which dictate the specificity of this interaction have remained elusive. Amino acid residues on the surface of basic FGF (bFGF) were targeted as potential heparin contacts on the basis of the position of sulfate anions in the X-ray crystal structure of bFGF and of a modeled pentasaccharide heparin-bFGF complex. Each identified amino acid was replaced individually with alanine by site-directed mutagenesis, and the resulting mutant proteins were characterized for differences in binding to a low molecular weight heparin (approximately 3000) by isothermal titrating calorimetry and also for differences in [NaCl] elution from a heparin-Sepharose affinity resin. The combination of site-directed mutagenesis and titrating calorimetry permitted an analysis of the energetic contributions of individual bFGF residues in the binding of heparin to bFGF. The key amino acids which comprise the heparin binding domain on bFGF constitute a discontinuous binding epitope and include K26, N27, R81, K119, R120, T121, Q123, K125, K129, Q134, and K135. Addition of the observed delta delta G degrees of binding for each single site mutant accounts for 8.56 kcal/mol (> 95%) of the free energy of binding. The delta delta G degrees values for N27A, R120A, K125A, and Q134A are all greater than 1 kcal/mol each, and these four amino acids together contribute 4.8 kcal/mol (56%) to the total binding free energy. Amino acid residues K119 through K135 reside in the C-terminal domain of bFGF and collectively contribute 6.6 kcal/mol (76%) of the binding free energy. Although 7 out of the 11 identified amino acids in the heparin binding domain are positively charged, a 7-fold increase in [NaCl] decreases the affinity of wild-type bFGF binding to heparin only 37-fold (Kd at 0.1 M NaCl = 470 nM vs Kd at 0.7 M NaCl = 17.2 microM). This indicates that pure electrostatic interactions contribute only 30% of the binding free energy as analyzed by polyelectrolyte theory and that more specific nonionic interactions, such as hydrogen bonding and van der Waals packing, contribute the majority of the free energy for this binding reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manning, G. S. (1978) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500002031 · Cited by 2,937
Rapid measurement of binding constants and heats of binding using a new titration calorimeter
Wiseman, T., Williston, S., Brandts, J. F., & Lin, L.-N. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90213-3 · Cited by 2,675
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Record, M. T., Anderson, C. F., & Lohman, T. M. (1978) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350000202x · Cited by 1,673
Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
Rapraeger, A. C., Krufka, A., & Olwin, B. B. (1991) · Science · doi:10.1126/science.1646484 · Cited by 1,508
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., & Klagsbrun, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2292 · Cited by 1,032
Ion effects on ligand-nucleic acid interactions
Record, M. T., Lohman, T. M., & Haseth, P. D. (1976) · Journal of Molecular Biology · doi:10.1016/s0022-2836(76)80023-x · Cited by 1,026
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Cunningham, B. C., Ultsch, M., de Vos, A. M., Mulkerrin, M. G., Clauser, K. R., & Wells, J. A. (1991) · Science · doi:10.1126/science.1948064 · Cited by 874
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Saksela, O., Moscatelli, D., Sommer, A., & Rifkin, D. B. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.2.743 · Cited by 804
Moscatelli, D. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041310118 · Cited by 646
Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., & Leder, P. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.240 · Cited by 632
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J., & Vlodavsky, I. (1989) · Biochemistry · doi:10.1021/bi00430a047 · Cited by 590
A dual receptor system is required for basic fibroblast growth factor activity
Klagsbrun, M., & Baird, A. (1991) · Cell · doi:10.1016/0092-8674(91)90173-v · Cited by 582
An Essential Heparin-Binding Domain in the Fibroblast Growth Factor Receptor Kinase
Kan, M., Wang, F., Xu, J., Crabb, J. W., Hou, J., & McKeehan, W. L. (1993) · Science · doi:10.1126/science.8456318 · Cited by 516
Molecular cloning of syndecan, an integral membrane proteoglycan.
Saunders, S., Jalkanen, M., O'Farrell, S., & Bernfield, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.4.1547 · Cited by 508
Nabel, E. G., Yang, Z.-Y., Plautz, G., Forough, R., Zhan, X., Haudenschild, C. C., Maciag, T., & Nabel, G. J. (1993) · Nature · doi:10.1038/362844a0 · Cited by 367
Neufeld, G., & Gospodarowicz, D. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38804-x · Cited by 345
Receptor- and heparin-binding domains of basic fibroblast growth factor.
Baird, A., Schubert, D., Ling, N., & Guillemin, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2324 · Cited by 320
Sommer, A., & Rifkin, D. B. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380129 · Cited by 304
Three-dimensional structure of human basic fibroblast growth factor.
Eriksson, A. E., Cousens, L. S., Weaver, L. H., & Matthews, B. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3441 · Cited by 284
Moscatelli, D. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.2.753 · Cited by 272
Recombinant basic fibroblast growth factor accelerates wound healing
McGee, G. S., Davidson, J. M., Buckley, A., Sommer, A., Woodward, S. C., Aquino, A. M., Barbour, R., & Demetriou, A. A. (1988) · Journal of Surgical Research · doi:10.1016/0022-4804(88)90034-0 · Cited by 265
Zhang, J. D., Cousens, L. S., Barr, P. J., & Sprang, S. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3446 · Cited by 250
Flaumenhaft, R., Moscatelli, D., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.4.1651 · Cited by 244
Nugent, M. A., & Edelman, E. R. (1992) · Biochemistry · doi:10.1021/bi00152a026 · Cited by 236
Olson, S. T., & Björk, I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38125-0 · Cited by 220
Davidson, J. M., Klagsbrun, M., Hill, K. E., Buckley, A., Sullivan, R., Brewer, P. S., & Woodward, S. C. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.4.1219 · Cited by 214
Klagsbrun, M., & Shing, Y. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.805 · Cited by 212
Nature of the interaction of heparin with acidic fibroblast growth factor
Mach, H., Volkin, D. B., Burke, C. J., Middaugh, C. R., Linhardt, R. J., Fromm, J. R., Loganathan, D., & Mattsson, L. (1993) · Biochemistry · doi:10.1021/bi00071a026 · Cited by 189
Stimulation of Growth of Keratinocytes by Basic Fibroblast Growth Factor
O'keefe, E. J., Chiu, M. L., & Payne, R. E. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12560956 · Cited by 169
Ishihara, M., Tyrrell, D. J., Stauber, G. B., Brown, S., Cousens, L. S., & Stack, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53449-9 · Cited by 137
[9] Isolation and characterization of acidic and basic fibroblast growth factor
Gospodarowicz, D. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)47102-4 · Cited by 131
Heparan sulphate in the binding and activation of basic fibroblast growth factor
Gallagher, J. T., & Turnbull, J. E. (1992) · Glycobiology · doi:10.1093/glycob/2.6.523 · Cited by 111
Binding of heparin to basic fibroblast growth factor induces a conformational change
Prestrelski, S. J., Fox, G. M., & Arakawa, T. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90401-h · Cited by 103
Moses, M. A., & Langer, R. (1991) · Nature Biotechnology · doi:10.1038/nbt0791-630 · Cited by 103
Hata, A., Ridinger, D. N., Sutherland, S., Emi, M., Shuhua, Z., Myers, R., Ren, K., Cheng, T. C., Inoue, I., & Wilson, D. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52896-9 · Cited by 102
Zhu, X., Hsu, B. T., & Rees, D. C. (1993) · Structure · doi:10.1016/0969-2126(93)90006-3 · Cited by 89
Crystal Structure of Basic Fibroblast Growth Factor at 1.6 Å Resolution
Ago, H., Kitagawa, Y., Fujishima, A., et al. (1991) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123586 · Cited by 87
Seno, M., Sasada, R., Kurokawa, T., & Igarashi, K. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15395.x · Cited by 77
Heparin-induced conformational change and activation of mucus proteinase inhibitor
Faller, B., Mély, Y., Gérard, D., & Bieth, J. G. (1992) · Biochemistry · doi:10.1021/bi00150a023 · Cited by 74
Harper, J. W., & Lobb, R. R. (1988) · Biochemistry · doi:10.1021/bi00402a027 · Cited by 60
Site-directed mutagenesis of a putative heparin binding domain of avian lipoprotein lipase.
Berryman, D. E., & Bensadoun, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53689-9 · Cited by 39
Heath, W. F., Cantrell, A. S., Mayne, N. G., & Jaskunas, S. R. (1991) · Biochemistry · doi:10.1021/bi00236a039 · Cited by 34
Cited by
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., & Marks, R. M. (1997) · Nature Medicine · doi:10.1038/nm0897-866 · Cited by 1,063
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Heparin and heparan sulfate: Structure and function
Rabenstein, D. L. (2002) · Natural Product Reports · doi:10.1039/b100916h · Cited by 870
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Metadata
- Authors
- Thompson, L. D., Pantoliano, M. W., & Springer, B. A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1994-04-05
- Volume
- 33
- Issue
- 13
- Pages
- 3831-3840
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2050082215
- Cited by
- 302
- References
- 48
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.